The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant PD-1 inhibitor combined with Nab-paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NCT05522985): A randomized, controlled, open label, phase II clinical trial.
 
Hongling Wang
No Relationships to Disclose
 
Xudong Wang
No Relationships to Disclose
 
Yanwei Li
No Relationships to Disclose
 
Peiguo Wang
No Relationships to Disclose
 
Ximei Zhang
No Relationships to Disclose
 
Yi Pan
No Relationships to Disclose
 
Ruifen Cheng
No Relationships to Disclose
 
Jianyu Xiao
No Relationships to Disclose